Novocure.com
It seems we can’t find what you’re looking for. Perhaps searching can help.
search
KEYNOTE B36
Lung Cancer
The KEYNOTE B36 study is intended for patients who have been diagnosed with, but have not yet been treated for, advanced or metastatic intrathoracic non-small cell lung cancer (NSCLC).